Copper and zinc metabolism in aminonucleoside-induced nephrotic syndrome.
Copper (Cu) and zinc (Zn) were measured in urine, serum and tissues from rats with nephrotic syndrome (NS) induced with a single subcutaneous dose of puromycin aminonucleoside (PAN; 15 mg/100 g BW). Control animals were pair-fed. Urine was collected daily, and the rats were sacrificed on day 10. PAN-nephrotic rats had proteinuria (days 3-10), high urinary Cu (days 1, 2, 4-10) and Zn (days 3-10) excretion. On day 10, nephrotic rats had: (a) albuminuria, hypoalbuminemia, hypoproteinemia, high urine and low serum levels of ceruloplasmin; (b) low Cu and Zn serum levels; (c) high clearance and fractional excretion of Cu and Zn, and (d) low kidney and liver Cu content and essentially normal tissue Zn levels. The alterations in Cu metabolism were more intense than those in Zn metabolism. Urine Cu and Zn showed a positive correlation with urine total protein on days 3-10 which suggests that high urinary excretion of Cu and Zn may be due to the excretion of its carrier proteins. In conclusion, these rats did not show a typical Zn deficiency but a clear decrease in Cu in the liver and kidney.
Pedraza-Chaverrí
J
J
Department of Nephrology and Mineral Metabolism, Instituto Nacional de la Nutrición Salvador Zubirán, México, DF Mexico.
Torres-Rodríguez
G A
GA
Cruz
C
C
Mainero
A
A
Tapia
E
E
Ibarra-Rubio
M E
ME
Silencio
J L
JL
D000818:Animals; D003300:Copper / Q000172:deficiency / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D009404:Nephrotic Syndrome / Q000139:chemically induced / Q000378:metabolism*; D011507:Proteinuria / Q000378:metabolism; D011692:Puromycin Aminonucleoside / Q000633:toxicity; D051381:Rats; D017208:Rats, Wistar; D014018:Tissue Distribution; D015032:Zinc / Q000172:deficiency / Q000378:metabolism*
D011692:Puromycin Aminonucleoside; D003300:Copper; D015032:Zinc